David A Henry1, Suzanne R Hill, Anthony Harris. Show Affiliations » 1. School of Medicine and Public Health, University of Newcastle, New South Wales, Australia. david.henry@newcastle.edu.au
Abstract
Mesh: See more » AustraliaCost-Benefit AnalysisDrug CostsDrug EvaluationDrug Industry/organization & administrationEconomics, PharmaceuticalHumansInsurance, Pharmaceutical ServicesPolicy MakingQuality-Adjusted Life YearsState Medicine/economicsTechnology Assessment, Biomedical/economicsTechnology Assessment, Biomedical/organization & administrationTreatment OutcomeUnited Kingdom
Year: 2005 PMID: 16304078 DOI: 10.1001/jama.294.20.2630
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272